Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children

BioMed Research International
Antonio SorlozanoJosé Gutiérrez-Fernández

Abstract

Background. The objective of this study was to identify the bacteria most frequently responsible for urinary tract infection (UTI) in the population of under-2-year-olds in our geographic area and to evaluate the activity of antibiotics widely used for UTI treatment during a 4-year study period.Materials and Methods.A retrospective analysis was conducted of data on the identification and susceptibility of microorganisms isolated in urine samples from children under 2 years of age.Results.A total of 1,045 uropathogens were isolated.Escherichia coliaccounted for the majority (60.3%) of these, followed byEnterococcus faecalis(22.4%) andKlebsiellaspp. (6.5%). The highestE. colisusceptibility rates (>90%) were to piperacillin-tazobactam, cefuroxime, cefotaxime, ceftazidime, imipenem, gentamicin, nitrofurantoin, and fosfomycin, and the lowest were to amoxicillin-clavulanic acid and cotrimoxazole. Among all bacteria isolated, we highlight the overall high activity of piperacillin-tazobactam, imipenem, nitrofurantoin, and fosfomycin against both community and hospital isolates and the reduced activity of amoxicillin-clavulanic acid, cephalosporins, gentamicin, and cotrimoxazole. There was no significant change in the total activity of ...Continue Reading

References

Aug 31, 2000·Actas urologicas españolas·J A Queipo ZaragozáJ F Jiménez Cruz
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James J RahalSorana Segal-Maurer
Apr 30, 2003·Archives of Disease in Childhood·S Ladhani, W Gransden
Jun 29, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Maria HallerReinhard Berner
Feb 11, 2005·Enfermedades infecciosas y microbiología clínica·Antonia AndreuUNKNOWN Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios
Jun 23, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Maria BitsoriEmmanouil Galanakis
Apr 8, 2006·Current Opinion in Pediatrics·Stanley Hellerstein
Jul 6, 2007·BMJ : British Medical Journal·Giovanni MontiniGraziella Zacchello
Nov 10, 2007·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J M Eiros BouzaUNKNOWN Grupo Investigador del Proyecto
Dec 27, 2007·JAMA : the Journal of the American Medical Association·Nader ShaikhEllen R Wald
Aug 19, 2009·Antimicrobial Agents and Chemotherapy·Sofia MarakiMatthew E Falagas
Apr 20, 2010·Enfermedades infecciosas y microbiología clínica·Carmen Torres, Emilia Cercenado
Jul 30, 2014·The Cochrane Database of Systematic Reviews·Yvonne StrohmeierJonathan C Craig
Oct 4, 2014·American Journal of Infection Control·Antonio SorlozanoJosé Gutiérrez-Fernández
Feb 24, 2015·Paediatrics and International Child Health·Catrin E MooreChristopher M Parry

❮ Previous
Next ❯

Citations

Aug 22, 2018·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Adem AltunkolErcan Yeni
May 18, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Ayelet MintzRuben Bromiker
Aug 11, 2020·Tropical Medicine and Health·Ganendra Bhakta RayaKoya Ariyoshi
Mar 10, 2020·BioMed Research International·Mewan Salahalddin A AlrahmanKawa F Dizaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
Mercedes TreviñoStudy Group SOGAMIC for the study of resistance in Galicia
Journal of Clinical and Diagnostic Research : JCDR
Dnyaneshwari Purushottam GhadageArvind Vamanrao Bhore
© 2022 Meta ULC. All rights reserved